JPRN-UMIN000013308已完成未知
Effect of apixaban for anti-atherosclerotic response in atrial fibrillation patients - Effect of apixaban for anti-atherosclerotic response in atrial fibrillation patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •High risk for bleeding Renal failure severe infection and trauma,perioperaion History of allergy to apixaban Ineligible in the opinion of investigators
研究者
相似试验
招募中
不适用
Effect of rivaroxaban for anti-atherosclerotic response in atrial fibrillation patientsatrial fibrillationJPRN-UMIN000011129Yokohama Sakae Kyosai Hospital50
已完成
不适用
Reversal of Apixaban Induced Alterations in Hemostasis by Different Coagulation Factor Concentrates: Combined in Vitro and Ex Vivo Dose Finding StudyI80Phlebitis and thrombophlebitisDRKS00007577Charité Campus Virchow-Klinikum24
已完成
不适用
Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf)Atrial FibrillationNCT03441633Pfizer51,690
尚未招募
3 期
A Trial To assess role of thromboprophylaxis by Apixaban in Advanced Epithelial Ovarian Cancer patients receiving Neoadjuvant ChemotherapyCTRI/2024/06/068730All India Institute of Medical Sciences
终止
3 期
Phase III Acute Coronary SyndromeAcute Coronary SyndromeNCT00831441Bristol-Myers Squibb7,484